Iqvia Holdings (IQV) Cash & Current Investments (2011 - 2026)
Iqvia Holdings' (IQV) quarterly Cash & Current Investments came in at $2.1 billion in Q2 2026, down 4.94% year-over-year from $2.2 billion in Q2 2025, and down 1.09% quarter-over-quarter from $2.1 billion in Q1 2026.
Analysis
Iqvia Holdings (IQV) Cash & Current Investments (2011 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Cash & Current Investments across 16 years of filings, most recently posting $2.1 billion for Q2 2026.
- In Q2 2026, Cash & Current Investments fell 4.94% year-over-year to $2.1 billion; the TTM figure through Jun 2026 stood at $2.1 billion (down 4.94% YoY), while the FY2025 annual figure was $2.1 billion, up 16.17% from the prior year.
- Cash & Current Investments came in at $2.1 billion for Q2 2026 at Iqvia Holdings, down from $2.1 billion in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $2.2 billion in Q2 2025 to a low of $1.3 billion in Q4 2022.
- Average Cash & Current Investments over 5 years is $1.7 billion, with a median of $1.6 billion recorded in 2023.
- Year-over-year, Cash & Current Investments plunged 37.84% in 2022 and soared 30.39% in 2025.
- Over 5 years, Cash & Current Investments stood at $1.3 billion in 2022, then climbed by 14.29% to $1.5 billion in 2023, then gained by 23.2% to $1.8 billion in 2024, then climbed by 16.17% to $2.1 billion in 2025, then fell by 2.85% to $2.1 billion in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $2.1 billion in Q2 2026, $2.1 billion in Q1 2026, and $2.1 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 2.08 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 502.69 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 928.39 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 192.03 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 168.60 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 425.88 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 84.54 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 4.40 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 5.47 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.08 Bn |
| Mar 31, 2026 | 2.10 Bn |
| Dec 31, 2025 | 2.14 Bn |
| Sep 30, 2025 | 1.97 Bn |
| Jun 30, 2025 | 2.19 Bn |
| Mar 31, 2025 | 1.88 Bn |
| Dec 31, 2024 | 1.84 Bn |
| Sep 30, 2024 | 1.71 Bn |
| Jun 30, 2024 | 1.68 Bn |
| Mar 31, 2024 | 1.58 Bn |
| Dec 31, 2023 | 1.50 Bn |
| Sep 30, 2023 | 1.33 Bn |
| Jun 30, 2023 | 1.49 Bn |
| Mar 31, 2023 | 1.60 Bn |
| Dec 31, 2022 | 1.31 Bn |
| Sep 30, 2022 | 1.36 Bn |
| Jun 30, 2022 | 1.52 Bn |
| Mar 31, 2022 | 1.49 Bn |
| Dec 31, 2021 | 1.48 Bn |
| Sep 30, 2021 | 1.57 Bn |